Questions To Ask At Your Weight Loss Medication Follow-Up Visit
For anyone on a weight loss medication, follow-up visits are a key part of the treatment plan.
By Harbor Health Team
Dosing schedules, side effects, plateaus, and what happens after the last injection. Every article written and reviewed by Harbor’s medical team.

115 articles, page 8 of 10
Newest first

For anyone on a weight loss medication, follow-up visits are a key part of the treatment plan.
By Harbor Health Team

Many people looking for modern medical weight management end up comparing semaglutide vs. tirzepatide.
By Harbor Health Team

GLP-1 injections have become a popular tool for weight loss, especially among people with obesity.
By Harbor Health Team

Losing weight is a challenge that millions of people face, and sometimes diet and exercise alone aren’t enough.
By Harbor Health Team

GLP-1 medications like semaglutide and tirzepatide suppress appetite, reduce caloric intake, and produce significant weight loss.
By Harbor Health Team

Hydration is one of the most frequently mentioned recommendations for patients on GLP-1 medications like semaglutide and tirzepatide, yet it is also one of the least well-explained.
By Harbor Health Team

One of the most common challenges patients face during semaglutide treatment is eating enough of the right things.
By Harbor Health Team

GLP-1 medications like semaglutide and tirzepatide produce weight loss that is predominantly fat, but not exclusively fat.
By Harbor Health Team
Alcohol is one of the most common topics that patients on GLP-1 medications ask about but hesitate to bring up during clinical visits.
By Harbor Health Team

Tirzepatide is one of the most effective weight-loss medications ever studied, with clinical trial data showing average body-weight reductions exceeding 20% over 72 weeks.
By Harbor Health Team

One of the most common questions patients ask before starting semaglutide is simple: how much weight will I actually lose, and how fast? The clinical trial headlines are impressive, 14.9% average body weight reduction in the STEP 1 trial, but averages don't tell you what to expect in any given week or month.
By Harbor Health Team

The clinical evidence for GLP-1 medications such as semaglutide and tirzepatide shows clinically meaningful weight loss during active treatment.
By Harbor Health Team
